Common mechanisms of Wumei pills in treating ulcerative colitis and type 2 diabetes: Exploring an integrative approach through network pharmacology

Chang Sun,Keyuan Xiao,Yinxiong He,Xinghua Li

DOI: https://doi.org/10.1097/md.0000000000037094

IF: 1.6

2024-02-03

Medicine

Abstract:Ulcerative colitis (UC) is a chronic, nonspecific inflammatory condition that impacts the rectum and colon, its etiology remaining elusive. The condition is marked by gastrointestinal symptoms, including abdominal pain, diarrhea, mucopurulent bloody stools, and tenesmus. [ 1 ] Furthermore, UC can result in complications in various organ systems, such as the musculoskeletal system, skin, liver, biliary tract, and eyes. [ 2 ] Conversely, type 2 diabetes (T2DM) is a chronic metabolic disorder marked by elevated blood sugar levels resulting from inadequate insulin production or cellular insulin resistance. Clinical manifestations include polydipsia, polyphagia, polyuria, emaciation, and fatigue due to a combination of metabolic dysregulations. [ 3 ] T2DM represents more than 90% of all diabetes cases. [ 4 ] UC is frequently diagnosed in Chinese young adults, peaking between the ages of 20 and 49. [ 5 ] Simultaneously, diabetes is on the rise among younger individuals, showing a prevalence rate of 11.2% in those aged 18 and above from 2015 to 2017. Currently, medications employed for UC and T2DM treatment can alleviate symptoms and decelerate disease progression but frequently carry notable side effects. [ 6 , 7 ]

medicine, general & internal